Scout Bio Announces Appointment of Chief Manufacturing
Experienced global animal health biologics executive to drive manufacturing strategies and advance pipeline of multiple animal health monoclonal antibodies...
Source: globenewswire.com
📰 Gene Therapy Program News
Page 8 - Gene Therapy Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gene Therapy Program. Real-time updates on events, politics, business and more.
Scout Bio Announces Appointment of Chief Manufacturing Officer
PHILADELPHIA, July 01, 2022 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company revolutionizing pet medicine by delivering a pipeline of monoclonal antibodies and one-time AAV gene therapies for chronic animal
University Of Pennsylvania United States Scout Bio Ray Oconnor Fran Gaconnier Scout Bio Nexvet Biopharma
Source: kulr8.com
Scout Bio To Present Positive Clinical Data On SB-001 For Feline CKD-Anemia at Leading Veterinary Medicine Forum
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Scout Bio To Present Positive Clinical Data On SB-001 For
Scout Bio’s research was selected for presentation at the American College of Veterinary Internal Medicine (ACVIM) ForumThree lectures will present Scout...
Source: globenewswire.com
Scout Bio To Present Positive Clinical Data On SB-001 For Feline CKD-Anemia at Leading Veterinary Medicine Forum - Press Release
Scout Bio's research was selected for presentation at the American College of Veterinary Internal Medicine (ACVIM) ForumThree lectures will present Sc
Source: wiredprnews.com
Taysha Gene Therapies Announces Annual Stockholder Meeting
The Annual Stockholder Meeting on Friday, June 17, 2022 at 10 am ET...
United States Kimberly Lee Carolyn Hawley Taysha Gene Therapies Inc Company Contact Canale Communications
Source: globenewswire.com
Passage Bio, Inc.'s (PASG) CEO Bruce Goldsmith on Q1 2022 Results - Earnings Call Transcript
Passage Bio, Inc. (NASDAQ:NASDAQ:PASG) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Stuart Henderson - Vice President of Corporate Development and Investor...
Source: seekingalpha.com
Aruvant Announces Oral Presentation at American Society of Gene and Cell Therapy (ASGCT)
/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced that data demonstrating the...
United States Punam Malik Prnewswire Aruvant Sciences Cincinnati Comprehensive Sickle Cell Center American Society Of Gene Cincinnati Children Hospital Medical Center
Source: prnewswire.com
Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Soci
- Accepted abstracts to be presented as oral presentations and posters highlight preclinical development progress for ARCUS® gene editing therapiesDURHAM, N.C.--(BUSINESS WIRE)--$DTIL #ARCUS--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic...
United States Mei Burris Precision Biosciences Inc University Of Pennsylvania Gene Therapy Program Dtil Biosciences Inc American Society Of Gene Cell Therapy
Source: pharmiweb.com
Gamida Cell (NASDAQ:GMDA) and Passage Bio (NASDAQ:PASG) Head to Head Analysis
Gamida Cell (NASDAQ:GMDA – Get Rating) and Passage Bio (NASDAQ:PASG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability. Insider and Institutional Ownership 53.4% of Gamida Cell shares […]
University Of Pennsylvania United States Israel General Gamida Cell Company Profile Get Rating Passage Bio Company Profile Get Rating Passage Bio Inc
Source: etfdailynews.com